As the partner in charge of health care services, pharmaceutical and medical device investing at Fort Worth, Texas-based TPG Capital LP for the past eight years, Todd Sisitsky has no down time.

In fact, he has been part of many of the headline-making deals at TPG, which has put out more than $6 billion in equity during the last six years. Most recently, Sisitsky oversaw the acquisition of Par Pharmaceuticals, the U.S.-based maker of approximately 55 generic drugs brands including versions of Paxil and Prozac. TPG paid $1.9 billion to take the company private, making it one of the largest health care deals since the U.S. Supreme Court upheld the Affordable Care Act.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.